Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy
Ploysyne Rattanakaemakorn, Prinpat Pinyowiwat, Wimolsiri Iamsumang, Kumutnart Chanprapaph, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat Suchonwanit; Kumutnart Chanprapaph...
Main Authors: | Rattanakaemakorn P, Pinyowiwat P, Iamsumang W, Chanprapaph K, Suchonwanit P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/incidence-and-risk-factors-of-hepatic-fibrosis-in-psoriatic-patients-r-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis
by: Tanat Yongpisarn, et al.
Published: (2022-12-01) -
The reverse of the coin: Methotrexate and liver fibrosis in a group of psoriatic arthritis patients
by: Andreea Lili Barbulescu, et al.
Published: (2020-12-01) -
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01) -
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
by: Qingfu Dong, et al.
Published: (2023-04-01) -
A review of liver fibrosis and cirrhosis regression
by: Michael J. Lee
Published: (2023-07-01)